Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+14.06%)
As of: Nov 16, 2026 · 12:26 PM EST

Elite Pharmaceuticals (ELTP) Receivables - Other (2009)

Updated

Elite Pharmaceuticals (ELTP) reported Receivables - Other of -$75,000 for fiscal Q3 2010 (quarter ended Dec 31, 2009).

Analysis

Elite Pharmaceuticals (ELTP) Receivables - Other (2009) Analysis & Trends

Dating back to fiscal Q4 2009, Elite Pharmaceuticals' Receivables - Other record includes 4 quarters.

  • Per Business Quant data, the three fiscal quarters before Q3 2010 came in at -$75,000 (Q2 2010), -$75,000 (Q1 2010) and -$75,000 (Q4 2009).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,291.18 Bn 1,264.79 Bn 20.46 Bn
2 Johnson & Johnson 686.56 Bn 606.42 Bn 17.30 Bn
3 AbbVie 525.29 Bn 493.30 Bn 13.12 Bn
4 Merck 362.24 Bn 325.18 Bn 13.19 Bn
5 Novartis Ag 313.66 Bn 286.90 Bn -
6 Astrazeneca 286.68 Bn 260.20 Bn 13.26 Bn
7 Amgen 253.44 Bn 205.10 Bn 7.58 Bn
8 Gilead Sciences 210.62 Bn 185.73 Bn 6.73 Bn
9 Pfizer 165.41 Bn 112.77 Bn 12.56 Bn
10 Elite Pharmaceuticals 397.46 Mn 270.87 Mn 15.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2009 -75,000.00
Sep 30, 2009 -75,000.00
Jun 30, 2009 -75,000.00
Mar 31, 2009 -75,000.00
API Access

Elite Pharmaceuticals Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=ELTP&period=max&api_key=YOUR_API_KEY